Cancer BiologybioRxivPreprint
Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a STING agonist
Peter K. Um, Monali Praharaj, Kara A. Lombardo…·Trinity Jude Bivalacqua
This study evaluates a recombinant BCG strain that releases a STING agonist, showing improved antitumor efficacy in bladder cancer models compared to wild-type BCG.